source
- STAT+: Pharmalittle: We’re reading about a GSK deal for a drug from China, job losses in the U.S., and moreGSK has continued its drive to bulk up its pipeline, taking global rights to a multiple myeloma treatment developed in China
- GSK to cut 650 jobs as it shuts German vaccine plant and consolidates production in CanadaGSK announced it will close its vaccine manufacturing facility in Dresden, Germany, resulting in about 650 layoffs. The decision follows a review and aligns with a $2.5 billion cost‑saving program…